Danish pharmaceutical giant Lundbeck acquires the American company Longboard, specialized in neurological diseases.
Lundbeck pays 2.6 billion dollars, equivalent to 27 billion kronor.
The Lundbeck share falls by around five percent on the Copenhagen Stock Exchange, while Longboard surges 45 percent in American pre-trading.
What do you think?